Lineage Cell Therapeutics
LCTX
#8906
Rank
NZ$0.35 B
Marketcap
NZ$1.41
Share price
-5.87%
Change (1 day)
-54.46%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2026 (TTM): -NZ$46.76 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are NZ$13.08 Million. In 2025 the company made an earning of -NZ$39.82 Million a decrease over its 2024 earnings that were of -NZ$39.27 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$46.76 Million17.43%
2025 -NZ$39.82 Million1.4%
2024 -NZ$39.27 Million-13.16%
2023 -NZ$45.22 Million9.83%
2022 -NZ$41.17 Million-54.24%
2021 -NZ$89.96 Million86.07%
2020 -NZ$48.35 Million-31.97%
2019 -NZ$71.07 Million-5.42%
2018 -NZ$75.14 Million1.1%
2017 -NZ$74.32 Million-31.06%
2016 -NZ$0.11 Billion-10.38%
2015 -NZ$0.13 Billion29.69%
2014 -NZ$92.76 Million31.68%
2013 -NZ$70.44 Million
2011 -NZ$34.19 Million89.78%
2010 -NZ$18.02 Million206.06%
2009 -NZ$5.89 Million-0.58%
2008 -NZ$5.92 Million164.89%
2007 -NZ$2.24 Million-30.22%
2006 -NZ$3.21 Million
2002 -NZ$3.72 Million-41.04%
2001 -NZ$6.31 Million-32.04%
2000 -NZ$9.29 Million-11.85%
1999 -NZ$10.53 Million
1997 -NZ$6.77 Million12.12%
1996 -NZ$6.04 Million106.25%
1995 -NZ$2.93 Million-11.11%
1994 -NZ$3.3 Million50%
1993 -NZ$2.2 Million20%
1992 -NZ$1.83 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.29 Billion 481.52%๐Ÿ‡บ๐Ÿ‡ธ USA